Gain Therapeutics Appoints Matthias Alder as Chief Operating Officer
BETHESDA, Md., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company...
News
VYNE Therapeutics Enrolls First Patient in Clinical Trial of FMX114 for the Treatment of Mild-to-Moderate Atopic Dermatitis
Important milestone achieved as part of the Company’s new corporate strategy to develop treatments for immuno-inflammatory diseases Topline results anticipated...
CinCor Pharma Appoints Mason Freeman, M.D., as Executive VP, Clinical Development
CINCINNATI, Oct. 19, 2021 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) today announced the appointment of Mason W. Freeman, M.D.,...
BioSyent Announces Launch of New FeraMAX® Pd Powder 15
FeraMAX Pd Powder 15 Package FeraMAX Pd Powder 15 Package MISSISSAUGA, Ontario, Oct. 19, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc....
Tauriga Sciences Inc. Enters into Strategic Alliance with Psychedelic Water
Tauriga 10-19-2021 Psychedelic Water Product Portfolio LAS VEGAS, Oct. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc....
Reflect Scientific Inc. Applies for Uplist to OTCQB Venture Market
OREM, Utah, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
Candel Therapeutics Appoints Mace L. Rothenberg, MD, as Senior Advisor to the Chief Executive Officer
NEEDHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late clinical stage biopharmaceutical company developing novel...
Proactive MD selects health care industry leader Dr. Saria Saccocio as company president
With a history of leading award-winning programs and improving the coordination and quality of care, Saccocio is passionate about helping...
First Patient Dosed in Phase IIa DMT-Assisted Therapy Clinical Trial
Phase IIa to explore the effectiveness of DMT in combination with psychotherapy for the potential treatment of Major Depressive Disorder...
Virbac : Declaration of the number of shares and voting rights 09/2021
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information...
Statera Biopharma, Inc. Announces Institutional Review Board Approves Study of STAT-205 for Acute COVID-19
Researchers at Loma Linda University Health to Evaluate Pharmacokinetics, Biomarkers and Safety of STAT-205 FORT COLLINS, Colo., Oct. 19, 2021...
Locus Biosciences Secures Financing of up to $25 Million from Hercules Capital
Proceeds to be used to advance development of synthetic biology engine and manufacturing capabilitiesRESEARCH TRIANGLE PARK, N.C., Oct. 19, 2021...
Plus Therapeutics Announces FDA Clearance of Investigational New Drug Application for 186RNL for the Treatment of Leptomeningeal Metastases
Patient accrual for the Phase 1 dose escalation clinical trial of 186RNL (ReSPECT-LM) is expected in the fourth quarter of...
Progenity to Participate in Crohn’s & Colitis Foundation’s Fourth Annual IBD Innovate Conference
SAN DIEGO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the...
Venus Concept Receives FDA 510(k) Clearance for the Venus Freedom™
TORONTO, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...
KemPharm, Inc. Announces Uplisting to The Nasdaq Global Select Market
Trading to commence effective with the open of business on October 19, 2021 CELEBRATION, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE)...
Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection
MENDHAM, N.J., and SOUTH SAN FRANCISCO, Calif, Oct. 19, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. and Assembly Biosciences, Inc....
Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021
Conference Call to Discuss Results on November 12, 2021 at 5:00am Pacific Time/8:00am Eastern TimeLOWELL, Mass., Oct. 19, 2021 (GLOBE...
InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19
Initial portion of the grant amounts to EUR 25.8 millionRemainder of the grant will be awarded in three additional milestone-dependent...
Artizan Biosciences Announces Appointment of Dr. Bridget Martell as President and Chief Executive Officer
Artizan Biosciences, Inc. Bridget Martell, M.A., M.D., President and Chief Executive Officer, Artizan Biosciences, Inc. NEW HAVEN, Conn., Oct. 19,...
